Brief: SSY Group Obtains Approval For Drug Production, Registration For Levocarnitine Oral Solution From NMPA
12/06/2025 11:50
June 12 (Reuters) - SSY Group Ltd 2005.HK: OBTAINED APPROVAL FOR DRUG PRODUCTION, REGISTRATION FOR LEVOCARNITINE ORAL SOLUTION FROM NMPA APPROVAL FOR DRUG PRODUCTION AND REGISTRATION FOR TRANEXAMIC ACID AND SODIUM CHLORIDE INJECTION (100ML) FROM NMPA Further company coverage: 2005.HK ((Reuters.Briefs@thomsonreuters.com))
Recent news on SSY
See all newsBrief: SSY Group Receives NMPA China Approval For Sodium Cromoglicate Eye Drops 2%
Brief: SSY Group Obtains NMPA Approval For Nimodipine Oral Solution
Brief: SSY Group Appoints Wu Heng Yao As Executive Director
Brief: SSY Group Says Ziprasidone Mesilate Receives Registration Approval In China
Hong Kong's SSY Group H1 profit rises on infusion solutions growth